Smarter Next Generation Innovation & Cost Effectiveness In Compound Management
As ageing compound management systems need to be renewed or replaced and market practices advance, companies are faced with different options from outsourcing to investing in new technologies in order to maintain momentum.
This choice leaves pharma firms with the challenge of not only achieving effective next generation innovation within compound management but also to innovate smartly in an economic sense.
Pharma IQ spoke to a selection of industry heavyweights on this matter to gain their insight.
Please note: That all fields marked with an asterisk (*) are required.